Dr. Wedel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Pavasiya Circle
Ivins, UT 84738Phone+1 951-296-7867
Education & Training
Johns Hopkins University School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1987 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea Start of enrollment: 2006 May 01
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment Start of enrollment: 2003 Feb 01
- Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715 Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 105 citationsA randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitisS. J. H. Van Deventer, J A Tami, Mark K. Wedel
Gut. 2004-11-01 - 40 citationsBioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.P. B. Miner, Richard S. Geary, John Matson, Emil Chuang, Shuting Xia
Alimentary Pharmacology & Therapeutics. 2006-05-01 - 97 citationsA phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative coli...S. J. H. Van Deventer, Mark K. Wedel, Brenda F. Baker, Shuting Xia, Emil Chuang
Alimentary Pharmacology & Therapeutics. 2006-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: